Shaileshkumar V Musley from Blaine, MN

Methods And Apparatus For Decreasing Incidences Of Early Recurrence Of Atrial Fibrillation
view source
US Patent:

20040210256, Oct 21, 2004
Filed:

Apr 17, 2003
Appl. No.:

10/417978
Inventors:

Shaileshkumar Musley - Blaine MN, US
Eduardo Warman - Maple Grove MN, US
David Euler - Minnetonka MN, US
Assignee:

Medtronic, Inc.
International Classification:

A61N001/39
US Classification:

607/005000
Abstract:

Implantable cardioverter/defibrillators (ICDs) providing atrial cardioversion/defibrillation (C/D) shock therapies in response to detected atrial tachyarrhythmias, particularly atrial fibrillation (AF) or in response to a patient command generated by a patient experiencing AF symptoms are disclosed. The early recurrence of atrial fibrillation (ERAF) following delivery of an atrial C/D shock is detected and delivery of any subsequent atrial C/D shock therapies is delayed for an ERAF sustained duration.

Medical Device To Provide Breathing Therapy
view source
US Patent:

20130030488, Jan 31, 2013
Filed:

Jul 28, 2011
Appl. No.:

13/192914
Inventors:

Yong K. Cho - Maple Grove MN, US
Shaileshkumar Musley - Blaine MN, US
Avram Scheiner - Vadnais Heights MN, US
Assignee:

Medtronic, Inc. - Minneapolis MN
International Classification:

A61N 1/36
A61N 1/365
US Classification:

607 20, 607 42
Abstract:

Medical devices and methods for providing breathing therapy (e.g., for treating heart failure, hypertension, etc.) may determine at least the inspiration phase of one or more breathing cycles based on the monitored physiological parameters and control delivery of a plurality of breathing therapy sessions (e.g., each of the breathing therapy sessions may be provided during a defined time period). Further, each of the plurality of breathing therapy sessions may include delivering stimulation after the start of the inspiration phase of each of a plurality of breathing cycles to prolong diaphragm contraction during the breathing cycle.

Identifying Lead Insulation Breaches And Externalization Of Lead Conductors
view source
US Patent:

20130304160, Nov 14, 2013
Filed:

Mar 14, 2013
Appl. No.:

13/803302
Inventors:

Walter H. Olson - North Oaks MN, US
ShaileshKumar V. Musley - Blaine MN, US
Jennifer P. Miller - Elk River MN, US
Assignee:

MEDTRONIC, INC. - Minneapolis MN
International Classification:

A61N 1/372
US Classification:

607 66
Abstract:

A technique for identifying lead-related conditions, such as insulation breaches and/or externalization of lead conductors, includes analyzing characteristics of electrical signals generated on one or more electrode sensing vectors of the lead by a test signal to determine whether a lead-related condition exists. The characteristics of the electrical signals induced on the lead by the test signal may be significantly different on a lead having an insulation breach or externalized conductor than on a lead not having such lead-related conditions. As such, the implantable medical device may be subject to a known test signal and analyze the signals on the lead to detect lead-related conditions.

System And Methods Of Determining Etiology Of Undiagnosed Symptomatic Events
view source
US Patent:

20180116598, May 3, 2018
Filed:

Nov 2, 2016
Appl. No.:

15/341465
Inventors:

- San Jose CA, US
ShaileshKumar V. MUSLEY - Blaine MN, US
Robert W. STADLER - Shoreview MN, US
Maneesh SHRIVASTAV - Blaine MN, US
Randal SCHULHAUSER - Phoenix AZ, US
Stacie VILENDRER - Santa Rosa CA, US
Assignee:

Medtronic Monitoring, Inc. - San Jose CA
International Classification:

A61B 5/00
A61B 5/0408
A61B 5/022
A61B 5/145
A61B 5/11
A61B 5/103
Abstract:

Embodiments describe a method of determining etiology of undiagnosed events comprising monitoring electrocardiogram signals and blood pressure of a patient via a medical device, capturing one or more of an ECG segment and a BP reading in response to a triggering event, classifying one or more of the ECG segment and BP reading as normal or abnormal, and determining etiology of undiagnosed symptomatic events based on the classification. Embodiments further describe a medical device comprising sensors for monitoring ECG signals and BP of a patient, circuitry for capturing one or more of ECG segments and BP readings of a patient in response to a triggering event, and a processor for communicating one of more of captured ECG segments and captured BP readings to a remote monitoring center directly or indirectly where the captured ECG segments and captured BP readings are classified as normal or abnormal.

Medical Device To Provide Breathing Therapy
view source
US Patent:

20160166831, Jun 16, 2016
Filed:

Aug 8, 2013
Appl. No.:

13/961963
Inventors:

- MINNEAPOLIS MN, US
Shaileshkumar V. Musley - Blaine MN, US
Avram Scheiner - Vadnais Heights MN, US
International Classification:

A61N 1/36
A61N 1/365
Abstract:

Medical devices and methods for providing breathing therapy (e.g., for treating heart failure, hypertension, etc.) may determine at least the inspiration phase of one or more breathing cycles based on the monitored physiological parameters and control delivery of a plurality of breathing therapy sessions (e.g., each of the breathing therapy sessions may be provided during a defined time period). Further, each of the plurality of breathing therapy sessions may include delivering stimulation after the start of the inspiration phase of each of a plurality of breathing cycles to prolong diaphragm contraction during the breathing cycle.

Shaileshkumar V Musley